Health Sciences Inc. Emerald serves as Executive at Nemus Bioscience, Inc., where they oversee executive responsibilities. Since joining the company, Health Sciences Inc. Emerald has executed 11 insider transactions totaling $813.3K, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 22, 2023 involved receiving (via award) 41,379,164 shares valued at $1.7M.
Health Sciences Inc. Emerald currently holds 73,153,917 shares of Nemus Bioscience, Inc. (NMUS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Health Sciences Inc. Emerald has been a net seller of NMUS stock. They have purchased $0 and sold $813.3K worth of shares.
Health Sciences Inc. Emerald's most recent insider trade was on Feb 22, 2023, when they sold 41,379,164 shares at $0.04 per share.
Get notified when new Form 4 filings are submitted
| $0.02 |
| Discretionary |
| Aug 7, 2020 | SKYE | $256.7K | Sale | 2,566,666 | $0.10 | Discretionary |
| Aug 7, 2020 | EMBI | $300.0K | Sale | 3,000,000 | $0.10 | Discretionary |
| Aug 7, 2020 | EMBI | $256.7K | Sale | 2,566,666 | $0.10 | Discretionary |
| Dec 20, 2019 | EMBI | $0 | Other | 40,800,000 | $N/A | Discretionary |
| Dec 27, 2018 | NMUS | $0 | Other | 37,667 | $N/A | Discretionary |
| Mar 29, 2018 | NMUS | $1.2M | Conversion | 12,335,000 | $0.10 | Discretionary |
| Mar 29, 2018 | NMUS | $2.0M | Conversion | 20,000,000 | $0.10 | Discretionary |
| Feb 16, 2018 | NMUS | $0 | Purchase | 15,000,000 | $N/A | Discretionary |
| Jan 24, 2018 | NMUS | $0 | Exercise | 1,781,250 | $N/A | Discretionary |